Gabapentin Tablet
Product Images NDC 72888-132

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72888-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Tablets 600 mg (NDC 72888-131-00)

Label for Gabapentin Tablets, USP 600 mg oral tablets by Advagen Pharma Ltd. The label indicates a bottle containing 1000 tablets, marked Rx only. It provides storage instructions, manufacturer details (Rubicon Research Private Limited, India), and advises pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Gabapentin Tablets 600 mg (NDC 72888-131-01)

Label for Gabapentin Tablets, USP 600 mg oral tablets, in a 100-tablet package. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. The label includes storage instructions, a barcode, and a pharmacist note to dispense the accompanying Medication Guide. Rev. date 11/21.*

FDA Label Image

Gabapentin Tablets 600 mg (NDC 72888-131-30)

Gabapentin Tablets, USP 600 mg oral tablets packaging label. Contains 30 tablets, labeled for prescription use only. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Label includes storage instructions, medication guide reference, and child safety warnings.*

FDA Label Image

Gabapentin Tablets 600 mg (NDC 72888-131-05)

Label for Gabapentin Tablets, USP 600 mg oral tablets, containing 500 tablets per bottle. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label includes storage instructions, a child-resistant container warning, and a reference to the medication guide at advagenpharma.com. The label also displays the NDC 72888-131-05 and a barcode.*

FDA Label Image

Gabapentin Tablets 800 mg (NDC 72888-132-30)

Gabapentin Tablets, USP 800 mg oral tablets label showing a quantity of 1000 tablets. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, Ambernath, India. The label includes storage instructions, the NDC number 72888-132-00, and a pharmacist dispensing note regarding the Medication Guide.*

FDA Label Image

Gabapentin Tablets 800 mg (NDC 72888-132-30)

Label for Gabapentin Tablets USP 800 mg, oral tablets packaged in a 100-count container. The label includes storage instructions, pharmacist dispensing warnings, and distributor information for Advagen Pharma Limited. The manufacturer is Rubicon Research Private Limited, India. The label displays the National Drug Code (NDC) 72888-132-01 and features a barcode.*

FDA Label Image

Gabapentin Tablets 800 mg (NDC 72888-132-30)

Gabapentin Tablets, USP 800 mg oral tablets label shows a 30-tablet package distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The label includes storage instructions, dosage directions to refer to the package insert, a child-resistant container warning, and a pharmacist notice to dispense the medication guide with each prescription.*

FDA Label Image

Gabapentin Tablets 800 mg (NDC 72888-132-30)

Gabapentin Tablets USP 800 mg oral tablets label showing 500 tablets per container. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited, India. The label features dosage strength prominently in blue, storage instructions, a barcode, and a medication guide website.*

FDA Label Image

Equation (Gabapentin Tabs Figure 01)

A formula for creatinine clearance (CLCr) calculation is shown, which includes variables for age in years, weight in kilograms, serum creatinine in mg/dL, and a correction factor for female patients. This text panel appears to be from pharmacokinetic or dosing information related to Gabapentin tablets by Advagen Pharma Ltd.*

FDA Label Image

Chemical Structure (Gabapentin Tabs Figure 02)

Chemical structure diagram of gabapentin, showing its molecular formula with a cyclohexane ring attached to amino and carboxyl functional groups.*

FDA Label Image

Figure 1 (Gabapentin Tabs Figure 03)

A line graph comparing mean pain scores over an 8-week period between placebo and gabapentin 3600 mg/day. The x-axis shows weeks from baseline to 8, and the y-axis shows mean pain scores from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period, with gabapentin showing a steady reduction in pain scores compared to placebo.*

FDA Label Image

Figure 2 (Gabapentin Tabs Figure 04)

A line graph depicting mean pain scores over a 7-week period comparing placebo with gabapentin dosed at 1800 mg/day and 2400 mg/day. The x-axis represents weeks from baseline to week 7, divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Data points for placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day are plotted and connected by lines.*

FDA Label Image

Figure 3 (Gabapentin Tabs Figure 05)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) at various doses across two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600. Study 2 shows 14% responders for placebo and 32% and 34% responders for GBP 1800 and GBP 2400, respectively. Statistical significance levels are noted with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapentin Tabs Figure 06)

A scatter plot comparing percentage difference versus daily dosages in milligrams (600 to 1800 mg) from three studies labeled as a, b, and c. Difference (%) is plotted on the vertical axis and daily dose on the horizontal axis, showing trends and comparison points among the studies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.